Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    NDDS- 2017 - International Conference and Exhibition on Pharmaceutical Novel Drug Delivery Systems

    View: 1008

    Website http://pharmaceutics.scientificsynergy.com/ | Want to Edit it Edit Freely

    Category Pharmaceutics, Drug Delivery Systems, Biopharmaceutics, Drug Administration

    Deadline: July 17, 2017 | Date: August 07, 2017-August 09, 2017

    Venue/Country: Philadelphia, U.S.A

    Updated: 2016-11-24 22:14:36 (GMT+9)

    Call For Papers - CFP

    Scientific Synergy Conferences is delighted to welcome you all to the "International Conference on Pharmaceutical and Novel Drug Delivery Systems", which will be during August 07-09, 2017 at Philadelphia USA

    NDDS-2017 conference focus on Recent development in micro, nano-drug delivery systems, novel pre-formulation, formulation approaches and strategies like diffusion controlled delivery have reoriented the focus of almost all the Pharmaceutical and Biopharmaceutical R&D’s towards Novel Drug Delivery Systems (NDDS), diverting a major section of research to focus on formulating a variety of poorly soluble and highly unstable substances, reporting it to be the significant arena in pharmaceutical research.

    NDDS-2017 conference is anticipating around 100+ participants around the globe and the three day conference will provoke plenary sessions, Keynote speeches, Posters, and Oral presentations.

    For any further details please email us and register soon.


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.